419 related articles for article (PubMed ID: 18939388)
21. [Nonalcoholic fatty liver disease].
Lemoine M; Serfaty L
Presse Med; 2012 Feb; 41(2):169-89. PubMed ID: 21723084
[TBL] [Abstract][Full Text] [Related]
22. The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.
Lindenmeyer CC; McCullough AJ
Clin Liver Dis; 2018 Feb; 22(1):11-21. PubMed ID: 29128051
[TBL] [Abstract][Full Text] [Related]
23. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
Nugent C; Younossi ZM
Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
[TBL] [Abstract][Full Text] [Related]
24. Treatment of fibrosis in nonalcoholic fatty liver disease.
Hoteit MA; Anania FA
Curr Gastroenterol Rep; 2007 Mar; 9(1):47-53. PubMed ID: 17335677
[TBL] [Abstract][Full Text] [Related]
25. Treating nonalcoholic fatty liver disease.
Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver disease.
Adams LA; Angulo P; Lindor KD
CMAJ; 2005 Mar; 172(7):899-905. PubMed ID: 15795412
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Massoud O; Charlton M
Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis and management issues for non-alcoholic fatty liver disease.
Duvnjak M; Lerotić I; Barsić N; Tomasić V; Virović Jukić L; Velagić V
World J Gastroenterol; 2007 Sep; 13(34):4539-50. PubMed ID: 17729403
[TBL] [Abstract][Full Text] [Related]
29. Current and future therapeutic strategies in NAFLD.
Mark N; de Alwis W; Day CP
Curr Pharm Des; 2010 Jun; 16(17):1958-62. PubMed ID: 20370671
[TBL] [Abstract][Full Text] [Related]
30. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
Lackner C
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
[TBL] [Abstract][Full Text] [Related]
32. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
Ong JP; Younossi ZM
Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
Souza MR; Diniz Mde F; Medeiros-Filho JE; Araújo MS
Arq Gastroenterol; 2012; 49(1):89-96. PubMed ID: 22481692
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and diagnosis of NAFLD/NASH.
Hashimoto E; Taniai M; Tokushige K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
[TBL] [Abstract][Full Text] [Related]
35. The metabolic syndrome and chronic liver disease.
Rosselli M; Lotersztajn S; Vizzutti F; Arena U; Pinzani M; Marra F
Curr Pharm Des; 2014; 20(31):5010-24. PubMed ID: 24320032
[TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
Milić S; Stimac D
Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
[TBL] [Abstract][Full Text] [Related]
38. [Non invasive markers of non-alcoholic steatohepatitis].
Raszeja-Wyszomirska J; Miezyńska-Kurtycz J; Marlicz W; Ławniczak M; Milkiewicz P
Pol Merkur Lekarski; 2008 Aug; 25(146):166-70. PubMed ID: 18942340
[TBL] [Abstract][Full Text] [Related]
39. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease as a complication of insulin resistance.
Abdelmalek MF; Diehl AM
Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
